Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by HOGARTH, M. B.
Right arrow Articles by PEPYS, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HOGARTH, M. B.
Right arrow Articles by PEPYS, M. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1997 Oxford University Press

research-article

Acute phase proteins, C-reactive protein and serum amyloid A protein, as prognostic markers in the elderly inpatient

MAXINE B. HOGARTH, J. RUTH GALLIMORE1, PHILIP SAVAGE, ALISON J. PALMER, JOHN M. STARR, CHRISTOPHER J. BULPITT and MARK B. PEPYS1,

Division of Geriatric Medicine, Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital Du Cane Road, London W12 0NN, UK
1Division of Immunological Medicine Unit, Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital Du Cane Road, London W12 0NN, UK

Address correspondence M. B. Pepys. Fax: (+44) 181 749 7478.

AIM:: to study the clinical significance and potential utility of measuring serum amyloid A protein (SAA) compared with the classical acute phase protein, C-reactive protein (CRP).

METHOD:: a 3 month prospective study on 66 women, mean age 83 years (range 69–106) and 33 men, mean age 84 years (range 69–95), admitted to the geriatric medicine unit at Hammersmith Hospital. CRP and SAA were determined on admission and at intervals throughout hospital stay; outcome end-points were death during the study, detection of infection, duration of admission and early re-admission to hospital after discharge.

RESULTS:: CRP and SAA responses were highly correlated (r = 0.75, P =0.0001). However, the SAA response was greater than that of CRP in most individuals, with a median ratio of initial SAA to CRP of 2.2 in patients with infective pathology and 1.6 in those with inflammatory pathology. Median (range) SAA on admission was 98 (0.1–940) mg/ml in patients with infection and was twice that observed in patients with other causes of inflammation, median value 50 (0.6–699) mg/l. There was no difference between median CRP on admission in patients with infection or inflammation, median value 53 (0.1 –235) and 51.5 (5 –246) mg/l respectively. Initial and peak levels of CRP, but not of SAA, were significantly greater in patients who subsequently died, whereas high levels of both proteins predicted length of admission and early re-admission.

CONCLUSION:: major elevations of the serum concentrations of CRP and SAA indicated serious disease and predicted poor outcome. Measurement of SAA as well as CRP enhanced the clinical utility of monitoring the acute phase response in 7% of patients with a diagnosis of infection.

Keywords: acute phase proteins, C-reactive protein, elderly inpatients, prognostic markers, serum amyloid A protein

Received September 4, 1996;
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.